Characteristics of SS-associated lymphoma patients, first-line treatments and CR rates, according to NHL subtypes.
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://figshare.com/articles/dataset/_Characteristics_of_SS_associated_lymphoma_patients_first_line_treatments_and_CR_rates_according_to_NHL_subtypes_/1319950
下载链接
链接失效反馈官方服务：
资源简介：
Abbreviations: SS = Sjögren's syndrome, MALTL = Mucosa-associated lymphoid tissue lymphoma, DLBCL = diffuse large B-cell lymphoma, NMZL = nodal marginal zone lymphoma, ESSDAI = EULAR Sjögren's syndrome disease activity index, IPI = International Prognostic Index, BM = Bone Marrow, SD = standard deviation, 2Cda = 2-chlorodeoxyadenosine, CHL = chlorambucil, CHOP = cyclophosphamide, doxorubicin, vincristine, prednisone, COP = cyclophosphamide, vincristine, prednisone, R = anti-CD20 (rituximab), C = cyclophosphamide, R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone, RF = rituximab, fludarabine, ESHAP = etoposide, methylprednisolone, cytarabine, cisplatin, CR = complete remission.
§Median follow-up times were computed by the reverse Kaplan-Meier method.
Characteristics of SS-associated lymphoma patients, first-line treatments and CR rates, according to NHL subtypes.
创建时间：
2015-02-27
